Press Release

PhRMA Announces Promotions of Key Federal Affairs Staff

PhRMA February 22, 2009

Washington, D.C. (January 22, 2009) — Underscoring a commitment to working with all stakeholders and policymakers to promote health care opportunities for America’s patients and to maintain the innovation that leads to the medicines of the future, the Pharmaceutical Research and Manufacturers of America (PhRMA) has promoted Bob Filippone and Tom Moore to the positions of Vice President, Federal Government Affairs. Filippone and Moore will join fellow Vice President Steve Tilton in reporting to Senior Vice President Bryant Hall.

Dr. Filippone, who has a PhD in international relations, came to PhRMA in 2004 after serving as Staff Director of the Senate Select Committee on Intelligence, as well as handling trade and foreign policy for Senator Bob Graham and serving as his Deputy Chief of Staff. Prior to his Senate service, Dr. Filippone worked in the Office of the Secretary of Defense, as a Missile Systems Engineer for the Raytheon Company, and as a Professor of International Relations at the Fletcher School of Law and Diplomacy. At PhRMA, he has been dedicated to various legislative and policy fronts, with a specific focus on the importance of maintaining protection of the intellectual property of life science innovators – from independent inventors to American’s pharmaceutical research companies – around the world, as well as opening foreign markets to innovative pharmaceutical products.

Moore rejoined PhRMA in May after working as Director of International Corporate Affairs for Amgen, Inc., a California-based biotechnology company and PhRMA member. At Amgen, Moore oversaw a variety of regions, including Central and Eastern Europe, Russia, and Latin America; in each area, he worked to expand the company’s clinical, regulatory, and commercial positions. Previously at PhRMA, he served as a Director of Federal Affairs through January 2005, working tirelessly toward the enactment of the Medicare Modernization Act, as well as other legislative efforts focused on promoting patient access to health care. Before joining PhRMA, he worked in the offices of then-Rep. Sherrod Brown and Rep. Darlene Hooley, and served six years as an infantryman in the Virginia Army National Guard.

“PhRMA has long been committed to supporting policies that help to maintain patient access to quality health care while promoting the innovation that represents the future of care worldwide,” said PhRMA President and CEO Billy Tauzin. “Bob Filippone and Tom Moore have both demonstrated that shared commitment.”

“Bob has proven a strong appreciation for the important role that intellectual property plays in the research and development that leads to new, life-changing medicines,” he added. ”Meanwhile, Tom’s commitment to patient access, as demonstrated through his work toward the immensely successful Medicare prescription drug benefit, underscores that innovative new medicines can only help those patients who have access to needed therapies.”

 The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.3 billion in 2009.

PhRMA Internet Address:
For information on how innovative medicines save lives, visit:
For information on the Partnership for Prescription Assistance, visit:
For more information on public health emergencies, visit
For information on the danger of imported drugs, visit: